Steven Cohen’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$397K Sell
18,606
-2,396
-11% -$45K ﹤0.01% 3276
2026
Q1
$367K Buy
+21,002
New +$417K ﹤0.01% 3278
2023
Q4
Sell
-217
Closed -$12.7K 2864
2023
Q3
$12.7K Buy
217
+208
+2,311% +$13K ﹤0.01% 2320
2023
Q2
$567 Buy
+9
New +$573 ﹤0.01% 2020
2019
Q4
Sell
-13,358
Closed -$914K 1265
2019
Q3
$914K Buy
13,358
+13,158
+6,579% +$883K 0.01% 708
2019
Q2
$16K Sell
200
-359
-64% -$28.5K ﹤0.01% 1264
2019
Q1
$47K Buy
+559
New +$58.3K ﹤0.01% 972

Other funds holding USNA

Steven Cohen's USNA Position: Q2 2026 in Review

Steven Cohen reduced its Usana Health Sciences (USNA) stake by 11% in Q2 2026, selling an estimated $45K and leaving 18,606 shares worth $397K. The position accounts for ﹤0.01% of the portfolio, ranked #3276.

Steven Cohen first reported a position in USNA in Q1 2019 and has held it in 7 quarters since. The position peaked at $914K in Q3 2019. 137 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Steven Cohen held 18,606 shares of Usana Health Sciences worth $397K as of Q2 2026.
  • Steven Cohen sold 2,396 Usana Health Sciences shares in Q2 2026, an estimated $45K.
  • Usana Health Sciences made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #3276 holding.
  • Steven Cohen first reported a position in Usana Health Sciences in Q1 2019 and has held it in 7 quarters since.
  • Steven Cohen's Usana Health Sciences position peaked at $914K in Q3 2019.
  • 137 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.